Design engineer Special Purpose Machinery

Your main fields of activity

  • Further development of existing products and independent development and construction of components and groups for special machines.
  • Management and coordination of customer-related projects from initial concept to commissioning
  • Management and coordination of external service providers
  • Customer advice, preparation of tenders and customer support

Your requirement profile

  • Technically experienced personality (graduate engineer or technician) with focus on design and automation
  • Good knowledge of 3D CAD design
  • Confident handling and experience with Inventor
  • Several years of professional experience, knowledge of special machine construction desirable
  • Good command of written and spoken English

Your personality

Highly committed, independent and focussed working manner, communicational skills

Our offer

  • A position at our company with diverse tasks
  • Integration into a dynamic team with the option of applying professional and personal skills to complex projects.

Your application

Have we aroused your interest? Then feel free to send your application documents including a photo, your earliest possible start date and salary expectations via email to

Mr. Rico Weinert

Dear Sir or Madam,
Dear Mr Weinert,

On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.

Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE